학술논문
1338P A phase III study comparing BCD-021, a bevacizumab biosimilar, and reference bevacizumab in patients with stage IIIB or IV non-squamous NSCLC
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S1022-S1022
Subject
Language
ISSN
0923-7534